|
Federal
Register Notices > Notice of
Application 2006 >
Aldrich Chemical Company Inc.
FR Doc E6-13849 [Federal Register: August 22, 2006 (Volume 71, Number 162)]
[Notices] [Page 48944] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22au06-78]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations
(CFR),
this is notice that on May 8, 2006, Aldrich Chemical Company Inc., DBA Isotec,
3858 Benner Road, Miamisburg, OH 45342-4304, made application by renewal, to the
Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of
the basic classes of controlled substances listed in Schedule I and II:
|
Drug
|
Schedule
|
|
Cathinone (1235)
|
I
|
|
Methcathinone (1237)
|
I
|
|
N-Ethylamphetamine (1475)
|
I
|
|
N,N-Dimethylamphetamine (1480)
|
I
|
|
Aminorex (1585)
|
I
|
|
Gamma hydroxybutyric acid (2010)
|
I
|
|
Methaqualone (2565)
|
I
|
|
Ibogaine (7260)
|
I
|
|
Lysergic acid dethylamide (7315)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Mescaline (7381)
|
I
|
|
2,5-Dimethoxyamphetamine (7396)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
3,4-Methylenedioxy-N-ethylamphetamine (7404)
|
I
|
|
3,4-Methylenedioxy-methamphetamine (7405)
|
I
|
|
4-Methoxyamphetamine (7411)
|
I
|
|
Psilocybin (7437)
|
I
|
|
Psilocyn (7438)
|
I
|
|
N-Ethyl-1-phenylcyclohexylamine (7455)
|
I
|
|
Dihydromorphine (9145)
|
I
|
|
Normorphine (9313)
|
I
|
|
Acetylmethadol (9601)
|
I
|
|
Alphacetylmethadol Except Levo-Alphacetylmethadol (9603) |
I
|
|
Normethadone (9635)
|
I
|
|
Norpipanone (9636)
|
I
|
|
3-Methylfentanyl (9813)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Methylphenidate (1724)
|
|
|
Amobarbital (2125)
|
II
|
|
Pentobarbital (2270)
|
II
|
|
Secobarbital (2315)
|
II
|
|
1-Phenylcyclohexylamine (7460)
|
II
|
|
Phencyclidine (7471)
|
II
|
|
Phenylacetone (8501)
|
II
|
|
1-Piperidinocyclohexanecarbonitrile (8603)
|
II
|
|
Cocaine (9041)
|
II
|
|
Codeine (9050)
|
II
|
|
Dihydrocodeine (9120)
|
II
|
|
Oxycodone (9143)
|
II
|
|
Hydromorphone (9150)
|
II
|
|
Benzoylecgonine (9180)
|
II
|
|
Ethylmorphine (9190)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Isomethadone (9226)
|
II
|
|
Meperidine (9230)
|
II
|
|
Meperidine intermediate-A (9232)
|
II
|
|
Merperidine intermediate-B (9233)
|
II
|
|
Methadone (9250)
|
II
|
|
Methadone intermediate (9254)
|
II
|
|
Dextropropoxyphene, bulk, (non-dosage forms) (9273) |
II
|
|
Morphine (9300)
|
II
|
|
Normorphine (9313)
|
II
|
|
Thebaine (9333)
|
II
|
|
Levo-alphacetylmethadol (9648)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture small quantities of the listed controlled
substances to produce isotope labeled standards for drug testing and analysis.
Any other such applicant and any person who is presently registered with DEA
to manufacture such a substance may file comments or objections to the issuance
of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections being sent via regular mail should be
addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, Washington, DC 20537,
Attention: DEA Federal Register Representative/ODL; or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal Register
Representative/ ODL, 2401 Jefferson-Davis Highway, Alexandria, VA 22301; and
must be filed no later than October 23, 2006.
Dated: August 15, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-13849 Filed 8-21-06; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
